Selected research
Industry Research
Animal Antibacterial and Antibiotics Industry Research Report 2026
Market perspective
The global Animal Antibacterial and Antibiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Animal Antibacterial and Antibiotics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Animal Antibacterial and Antibiotics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Animal Antibacterial and Antibiotics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Animal Antibacterial and Antibiotics include Biogénesis Bagó, Boehringer Ingelheim Vetmedica, Ceva Santé Animale, Dechra Pharmaceuticals, ECO Animal Health, Elanco, Huvepharma, Merial and Neogen, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Animal Antibacterial and Antibiotics market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Animal Antibacterial and Antibiotics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Antibacterial and Antibiotics Market by Company
Biogénesis Bagó
Boehringer Ingelheim Vetmedica
Ceva Santé Animale
Dechra Pharmaceuticals
ECO Animal Health
Elanco
Huvepharma
Merial
Neogen
Norbrook
Orion
Phibro Animal Health
Vétoquinol
Virbac
Vitafor
Bayer HealthCare
Merck Animal Health
Zoetis
Animal Antibacterial and Antibiotics Segment by Type
Cephalosporins
Tetracyclines
Penicillins
Sulfonamides
Macrolides
Aminoglycosides
Animal Antibacterial and Antibiotics Segment by Application
Livestock
Pets
Others
Animal Antibacterial and Antibiotics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Antibacterial and Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Antibacterial and Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Antibacterial and Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Animal Antibacterial and Antibiotics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cephalosporins
- Tetracyclines
- Penicillins
- Sulfonamides
- Macrolides
- Aminoglycosides
Applications
- Livestock
- Pets
- Others
Companies covered
- Biogénesis Bagó
- Boehringer Ingelheim Vetmedica
- Ceva Santé Animale
- Dechra Pharmaceuticals
- ECO Animal Health
- Elanco
- Huvepharma
- Merial
- Neogen
- Norbrook
- Orion
- Phibro Animal Health
- Vétoquinol
- Virbac
- Vitafor
- Bayer HealthCare
- Merck Animal Health
- Zoetis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Animal Antibacterial and Antibiotics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cephalosporins
- 2.2.3 Tetracyclines
- 2.2.4 Penicillins
- 2.2.5 Sulfonamides
- 2.2.6 Macrolides
- 2.2.7 Aminoglycosides
- 2.3 Animal Antibacterial and Antibiotics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Livestock
- 2.3.3 Pets
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Animal Antibacterial and Antibiotics Breakdown Data by Type
- 3.1 Global Animal Antibacterial and Antibiotics Historic Market Size by Type (2021-2026)
- 3.2 Global Animal Antibacterial and Antibiotics Forecasted Market Size by Type (2027-2032)
4 Animal Antibacterial and Antibiotics Breakdown Data by Application
- 4.1 Global Animal Antibacterial and Antibiotics Historic Market Size by Application (2021-2026)
- 4.2 Global Animal Antibacterial and Antibiotics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Animal Antibacterial and Antibiotics Market Perspective (2021-2032)
- 5.2 Global Animal Antibacterial and Antibiotics Growth Trends by Region
- 5.2.1 Global Animal Antibacterial and Antibiotics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Animal Antibacterial and Antibiotics Historic Market Size by Region (2021-2026)
- 5.2.3 Animal Antibacterial and Antibiotics Forecasted Market Size by Region (2027-2032)
- 5.3 Animal Antibacterial and Antibiotics Market Dynamics
- 5.3.1 Animal Antibacterial and Antibiotics Industry Trends
- 5.3.2 Animal Antibacterial and Antibiotics Market Drivers
- 5.3.3 Animal Antibacterial and Antibiotics Market Challenges
- 5.3.4 Animal Antibacterial and Antibiotics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Animal Antibacterial and Antibiotics Players by Revenue
- 6.1.1 Global Top Animal Antibacterial and Antibiotics Players by Revenue (2021-2026)
- 6.1.2 Global Animal Antibacterial and Antibiotics Revenue Market Share by Players (2021-2026)
- 6.2 Global Animal Antibacterial and Antibiotics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Animal Antibacterial and Antibiotics Head Office and Area Served
- 6.4 Global Animal Antibacterial and Antibiotics Players, Product Type & Application
- 6.5 Global Animal Antibacterial and Antibiotics Manufacturers Established Date
- 6.6 Global Animal Antibacterial and Antibiotics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Animal Antibacterial and Antibiotics Market Size (2021-2032)
- 7.2 North America Animal Antibacterial and Antibiotics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Animal Antibacterial and Antibiotics Market Size by Country (2021-2026)
- 7.4 North America Animal Antibacterial and Antibiotics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Animal Antibacterial and Antibiotics Market Size (2021-2032)
- 8.2 Europe Animal Antibacterial and Antibiotics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Animal Antibacterial and Antibiotics Market Size by Country (2021-2026)
- 8.4 Europe Animal Antibacterial and Antibiotics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Animal Antibacterial and Antibiotics Market Size (2021-2032)
- 9.2 Asia-Pacific Animal Antibacterial and Antibiotics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Animal Antibacterial and Antibiotics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Animal Antibacterial and Antibiotics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Animal Antibacterial and Antibiotics Market Size (2021-2032)
- 10.2 South America Animal Antibacterial and Antibiotics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Animal Antibacterial and Antibiotics Market Size by Country (2021-2026)
- 10.4 South America Animal Antibacterial and Antibiotics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Animal Antibacterial and Antibiotics Market Size (2021-2032)
- 11.2 Middle East & Africa Animal Antibacterial and Antibiotics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Animal Antibacterial and Antibiotics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Animal Antibacterial and Antibiotics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Biogénesis Bagó
- 12.1.1 Biogénesis Bagó Company Information
- 12.1.2 Biogénesis Bagó Business Overview
- 12.1.3 Biogénesis Bagó Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.1.4 Biogénesis Bagó Animal Antibacterial and Antibiotics Product Portfolio
- 12.1.5 Biogénesis Bagó Recent Developments
- 12.2 Boehringer Ingelheim Vetmedica
- 12.2.1 Boehringer Ingelheim Vetmedica Company Information
- 12.2.2 Boehringer Ingelheim Vetmedica Business Overview
- 12.2.3 Boehringer Ingelheim Vetmedica Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.2.4 Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Product Portfolio
- 12.2.5 Boehringer Ingelheim Vetmedica Recent Developments
- 12.3 Ceva Santé Animale
- 12.3.1 Ceva Santé Animale Company Information
- 12.3.2 Ceva Santé Animale Business Overview
- 12.3.3 Ceva Santé Animale Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.3.4 Ceva Santé Animale Animal Antibacterial and Antibiotics Product Portfolio
- 12.3.5 Ceva Santé Animale Recent Developments
- 12.4 Dechra Pharmaceuticals
- 12.4.1 Dechra Pharmaceuticals Company Information
- 12.4.2 Dechra Pharmaceuticals Business Overview
- 12.4.3 Dechra Pharmaceuticals Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.4.4 Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Product Portfolio
- 12.4.5 Dechra Pharmaceuticals Recent Developments
- 12.5 ECO Animal Health
- 12.5.1 ECO Animal Health Company Information
- 12.5.2 ECO Animal Health Business Overview
- 12.5.3 ECO Animal Health Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.5.4 ECO Animal Health Animal Antibacterial and Antibiotics Product Portfolio
- 12.5.5 ECO Animal Health Recent Developments
- 12.6 Elanco
- 12.6.1 Elanco Company Information
- 12.6.2 Elanco Business Overview
- 12.6.3 Elanco Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.6.4 Elanco Animal Antibacterial and Antibiotics Product Portfolio
- 12.6.5 Elanco Recent Developments
- 12.7 Huvepharma
- 12.7.1 Huvepharma Company Information
- 12.7.2 Huvepharma Business Overview
- 12.7.3 Huvepharma Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.7.4 Huvepharma Animal Antibacterial and Antibiotics Product Portfolio
- 12.7.5 Huvepharma Recent Developments
- 12.8 Merial
- 12.8.1 Merial Company Information
- 12.8.2 Merial Business Overview
- 12.8.3 Merial Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.8.4 Merial Animal Antibacterial and Antibiotics Product Portfolio
- 12.8.5 Merial Recent Developments
- 12.9 Neogen
- 12.9.1 Neogen Company Information
- 12.9.2 Neogen Business Overview
- 12.9.3 Neogen Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.9.4 Neogen Animal Antibacterial and Antibiotics Product Portfolio
- 12.9.5 Neogen Recent Developments
- 12.10 Norbrook
- 12.10.1 Norbrook Company Information
- 12.10.2 Norbrook Business Overview
- 12.10.3 Norbrook Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.10.4 Norbrook Animal Antibacterial and Antibiotics Product Portfolio
- 12.10.5 Norbrook Recent Developments
- 12.11 Orion
- 12.11.1 Orion Company Information
- 12.11.2 Orion Business Overview
- 12.11.3 Orion Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.11.4 Orion Animal Antibacterial and Antibiotics Product Portfolio
- 12.11.5 Orion Recent Developments
- 12.12 Phibro Animal Health
- 12.12.1 Phibro Animal Health Company Information
- 12.12.2 Phibro Animal Health Business Overview
- 12.12.3 Phibro Animal Health Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.12.4 Phibro Animal Health Animal Antibacterial and Antibiotics Product Portfolio
- 12.12.5 Phibro Animal Health Recent Developments
- 12.13 Vétoquinol
- 12.13.1 Vétoquinol Company Information
- 12.13.2 Vétoquinol Business Overview
- 12.13.3 Vétoquinol Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.13.4 Vétoquinol Animal Antibacterial and Antibiotics Product Portfolio
- 12.13.5 Vétoquinol Recent Developments
- 12.14 Virbac
- 12.14.1 Virbac Company Information
- 12.14.2 Virbac Business Overview
- 12.14.3 Virbac Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.14.4 Virbac Animal Antibacterial and Antibiotics Product Portfolio
- 12.14.5 Virbac Recent Developments
- 12.15 Vitafor
- 12.15.1 Vitafor Company Information
- 12.15.2 Vitafor Business Overview
- 12.15.3 Vitafor Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.15.4 Vitafor Animal Antibacterial and Antibiotics Product Portfolio
- 12.15.5 Vitafor Recent Developments
- 12.16 Bayer HealthCare
- 12.16.1 Bayer HealthCare Company Information
- 12.16.2 Bayer HealthCare Business Overview
- 12.16.3 Bayer HealthCare Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.16.4 Bayer HealthCare Animal Antibacterial and Antibiotics Product Portfolio
- 12.16.5 Bayer HealthCare Recent Developments
- 12.17 Merck Animal Health
- 12.17.1 Merck Animal Health Company Information
- 12.17.2 Merck Animal Health Business Overview
- 12.17.3 Merck Animal Health Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.17.4 Merck Animal Health Animal Antibacterial and Antibiotics Product Portfolio
- 12.17.5 Merck Animal Health Recent Developments
- 12.18 Zoetis
- 12.18.1 Zoetis Company Information
- 12.18.2 Zoetis Business Overview
- 12.18.3 Zoetis Revenue in Animal Antibacterial and Antibiotics Business (2021-2026)
- 12.18.4 Zoetis Animal Antibacterial and Antibiotics Product Portfolio
- 12.18.5 Zoetis Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst